Ambimetric glycated hemoglobin monitoring system - Taiwan Registration b153ac464eadddb3750a3a70f3bc004c
Access comprehensive regulatory information for Ambimetric glycated hemoglobin monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b153ac464eadddb3750a3a70f3bc004c and manufactured by Inner Lake Plant of AXA Shengke Co., Ltd. The authorized representative in Taiwan is IXENSOR CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is intended for in vitro diagnostics for the quantitative measurement of glycated hemoglobin (% HbA1c) in venous whole blood or fingertip blood samples. This product is intended for use by professionals only.
B Hematology, pathology, and genetics
B.7470 Analysis of glycosylated hemoglobin
QMS/QSD;; ๅ็ข
Dates and Status
Jul 10, 2019
Jul 10, 2029